Latest News
Latest News
More Access to Perinatal Mental Healthcare Needed
Despite federal legislation to increase mental healthcare access, the greater number of people receiving visits coincided with fewer visits per...
Feature
Immunotherapy May Be Overused in Dying Patients With Cancer
“There are patients who are getting immunotherapy who shouldn’t,” according to a surgical oncologist from Yale.
From the Journals
Modest Gains Shown in Breast Cancer Immunotherapy Trials
Researchers evaluated 331 immunotherapy trials, enrolling nearly 50,000 patients with breast cancer.
From the Journals
Can Addressing Depression Reduce Chemo Toxicity in Older Adults?
Researchers evaluated whether greater reductions in grade 3 chemotherapy-related toxicities occurred with geriatric assessment-driven...
Latest News
It’s in the Juice: Cranberries for UTI Prevention
The combination of liquid and cranberry compounds, in cranberry juice, provides clear and significant clinical outcomes for the reduction in UTIs...
From the Journals
Why Is Mom’s Type 1 Diabetes Half as Likely as Dad’s to Pass to Child?
Individuals with type 1 diabetes were almost twice as likely to have a father with the condition than a mother.
Latest News
Study Links Melasma With Comorbidities, Races, Ethnicities
Among those with melasma, 25% had hypertension and 24% used hormonal contraception, the two most commonly associated risk factors identified.
Opinion
The Mysterious Latch
Even under optimal conditions, not every woman and/or child can successfully breastfeed.
Latest News
Government Accuses Health System of Paying Docs Outrageous Salaries for Patient Referrals
Tennessee-based Erlanger Health System changed its compensation model to entice revenue-generating doctors.
Latest News
SUNY Downstate Emergency Medicine Doc Charged With $1.5M Fraud
EM doc accused of tax fraud, larceny, and falsifying records in case of using business credit card for personal expenses.
News from the FDA/CDC
FDA Approves First Engineered Cell Therapy for a Solid Tumor
This T-cell receptor therapy modifies existing receptors to recognize an array of antigens on the surface of cancer cells.